Protective Effects of PCSK9 Inhibitors on Renal Function in ASCVD Patients at High Risk for Contrast-Associated Acute Kidney Injury
Angiology: The Journal of Vascular Diseases
Published online on November 13, 2025
Abstract
Angiology, Ahead of Print.
The present study explored the potential protective effects of a proprotein-converting enzyme subtilisin/kexin 9 inhibitor (evolocumab) against contrast-associated acute kidney injury (CA-AKI) in high-risk patients with atherosclerotic cardiovascular ...
The present study explored the potential protective effects of a proprotein-converting enzyme subtilisin/kexin 9 inhibitor (evolocumab) against contrast-associated acute kidney injury (CA-AKI) in high-risk patients with atherosclerotic cardiovascular ...